0001596783-23-000126.txt : 20230901
0001596783-23-000126.hdr.sgml : 20230901
20230901135235
ACCESSION NUMBER: 0001596783-23-000126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230830
FILED AS OF DATE: 20230901
DATE AS OF CHANGE: 20230901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREISCH JOHN J
CENTRAL INDEX KEY: 0001278569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 231231935
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_169359074262075.xml
FORM 4
X0508
4
2023-08-30
0
0001596783
Catalent, Inc.
CTLT
0001278569
GREISCH JOHN J
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
1
1
0
0
Executive Chair
0
Common Stock
16196
D
Common Stock
2023-08-30
4
P
0
21000
50.24
A
34000
I
Through John J. Greisch 2014 Trust
Options to purchase Common Stock
48.98
2023-08-30
4
A
0
127096
0
A
2033-08-30
Common Stock
127096.0
127096
D
The number of securities reported reflects the forfeiture of 684 restricted stock units granted to the reporting person on October 27, 2022 upon the reporting person's appointment as an executive officer of the Issuer.
Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.97 to $50.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
The options vest and become exercisable in four equal annual installments beginning on August 30, 2024.
/s/ Amy Fallone, attorney-in-fact
2023-09-01